Stock Spotlight: IPH Limited (ASX:IPH)

This week's Stock Spotlight is ASX-listed IPH Limited.


About IPH Limited.


IPH Limited, together with its subsidiaries, provides intellectual property (IP) services and products. It operates through three segments: Australian and New Zealand IP, Canadian IP, and Asian IP. The company offers IP services related to the provision of filing, prosecution, enforcement, and management of patents, designs, trade marks, legal services, and other IP. It also engages in patent attorney, lawyers, support, and data analysis and software businesses. The company serves Fortune Global 500 companies, multinationals, public sector research organisations, SMEs, professional services firms, universities, foreign associates, and other corporate and individual clients. IPH Limited was founded in 1887 and is based in Sydney, Australia.



Source: Yahoo Finance



Key Stats

Source: Yahoo Finance, ASX. Data as of 04/08/25.


Price Performance

Growth Potential

  • Trades below our price target and blended valuation. The stock is also trading on an undemanding PE-multiple of 10.4x & dividend yield of 7.3%
  • Capital management – IPH’s share buyback commenced in Dec-24, looking to purchase shares up to $75m ($10.4m deployed to date).
  • Strong market positions – Leading market positions in Australia & Singapore.
  • Relatively defensive earnings, with a high degree of visibility and solid free cash flow profile.
  • Potential margin expansion on better efficiency gains and synergies from acquisitions.
  • Expansion into new markets and regions – South Africa, South America.
  • Offers a very attractive dividend yield (Company maintains high payout ratio of 80-90%)

Key Risks


  • Disappointing organic growth driven by lower patent filing volumes
  • Value destructive acquisition.
  • Cut dividends or the payout ratio policy.
  • Loss of market share, especially in a key region like Australia.
  • Cybersecurity attacks compromising client data.
  • Adverse movements in currencies.

Subscribe to our newsletter

Disclaimer: This article does not constitute financial advice nor a recommendation to invest in the securities listed. The information presented is intended to be of a factual nature only. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing.

Speak to an Advisor

The AI Trade Just Hit an Uncomfortable Question: What If Progress Slows?

September 15, 2026
The AI trade is being forced to rethink the pace of progress. Here is what investors should watch across Nvidia, chips, AI spending, software and adoption.

Copper Just Hit an All-Time High. But Where Is All the Copper?

September 9, 2026
Copper is at a record high, yet the global market still has a surplus. So where is all the copper, and why is it becoming harder to find?

AI Infrastructure, Not AI Hype: Alex Perry on Sharewise's Global Playbook

By Lavender Wong • September 1, 2026
Sharewise CEO Alex Perry sat down with ausbiz to unpack how the platform approached FY26, a year in which it reported an ASX return of almost 11% and a US return above 32%. The conversation ranged from the AI infrastructure theme to specific names on Perry's radar in resources and quantum computing. Here's a rundown of the key points.

Jackson Hole 2026: Warsh Sets Out the Fed’s New Policy Framework

August 31, 2026
Warsh gave markets a framework, not a forecast. What his first Jackson Hole keynote means for inflation, rates, forward guidance and the outlook for equities.

Stock Spotlight: Impact Minerals Limited​ (ASX: IPT)

August 26, 2026
Get the latest on Impact Minerals (ASX: IPT), including stock performance, technical analysis, forecasts & key insights. See if IPO supports your goals.

Stock Spotlight: Valiant Gold (ASX: VAL)

August 26, 2026
Get the latest on Valiant Gold (ASX: VAL) with our share price, technical analysis, forecasts & key insights. See if this ASX gold stock fits your investment goals.

Stock Spotlight: Percheron Therapeutics (ASX: PER)

August 26, 2026
Learn about Percheron Therapeutics (ASX: PER). Offering share price, technical analysis, forecasts & insights. See if this ASX biotech stock fits your goals.

Oil Is Back Above US$90 As Strait of Hormuz Risks Mount

August 19, 2026
Brent crude hits US$91 as US-Iran talks stall and Strait of Hormuz disruption persists. What's driving the move and what comes next for oil

Hawkish Hold: What the RBA's August Pause Really Signals

August 13, 2026
The RBA holds rates at 4.35% as inflation remains elevated. Here’s what the August decision means for the Australian economy, markets and key sectors.

From Compute to Cost: How AI's Next Phase Could Reshape Investment Winners

August 6, 2026
As AI becomes cheaper to deploy, could the next investment winners shift beyond chipmakers? Explore how the AI cost race is redefining future tech leaders.